Clinical Trial Update: A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for GR1802 in chronic rhinosinusitis with nasal polyps; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• GR1802 (GR1802)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: ACTIVE_NOT_RECRUITING